Dr. Carson Discusses Mogamulizumab as Potential Treatment for CTCL
9 Ansichten
• 08/09/23
0
0
Einbetten
administrator
Abonnenten
Kenneth R. Carson, MD, assistant professor, Division of Oncology, Washington University, discusses mogamulizumab as a potential treatment for patients with relapsed or refractory cutaneous T cell lymphoma (CTCL).
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare